|
1
|
Libby P and Hansson GK: Inflammation and
immunity in diseases of the arterial tree: Players and layers. Circ
Res. 116:307–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li B, Li W, Li X and Zhou H: Inflammation:
A novel therapeutic target/direction in atherosclerosis. Curr Pharm
Des. 23:1216–1227. 2017. View Article : Google Scholar
|
|
3
|
Gimbrone MA Jr and García-Cardeña G:
Endothelial cell dysfunction and the pathobiology of
atherosclerosis. Circ Res. 118:620–636. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Wang Y, Li Y, Wang S and Zhu X:
Platelet-rich plasma protects HUVECs against oX-LDL-induced injury.
Open Med (Wars). 13:41–52. 2018. View Article : Google Scholar
|
|
5
|
Kattoor AJ, Goel A and Mehta JL: LOX-1:
Regulation, signaling and its role in atherosclerosis. Antioxidants
(Basel). 8:2182019. View Article : Google Scholar
|
|
6
|
Mitra S, Deshmukh A, Sachdeva R, Lu J and
Mehta JL: Oxidized low-density lipoprotein and atherosclerosis
implications in anti-oxidant therapy. Am J Med Sci. 342:135–142.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin J, Hou X and Yang S: microRNA-338-3p
promotes ox-LDL-induced endothelial cell injury through targeting
BAMBI and activating TGF-β/Smad pathway. J Cell Physiol.
234:11577–11586. 2019. View Article : Google Scholar
|
|
8
|
Peng J, Tang ZH, Ren Z, He B, Zeng Y, Liu
LS, Wang Z, Wei DH, Zheng XL and Jiang ZS: TET2 protects against
oxLDL-Induced HUVEC dysfunction by upregulating the CSE/H2S system.
Front Pharmacol. 8:4862017. View Article : Google Scholar :
|
|
9
|
Zeng X, Lin W, Guo M and Zou Q: A
comprehensive overview and evaluation of circular RNA detection
tools. PLoS Comput Biol. 13:e10054202017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen I, Chen CY and Chuang TJ: Biogenesis,
identification, and function of exonic circular RNAs. Wiley
Interdiscip Rev RNA. 6:563–579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bayoumi AS, Aonuma T, Teoh JP, Tang YL and
Kim IM: Circular noncoding RNAs as potential therapies and
circulating biomarkers for cardiovascular diseases. Acta Pharmacol
Sin. 39:1100–1109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan RY, Zhao CH, Yuan JX, Zhang YJ, Jin
JL, Gu MF, Mao ZY, Sun HJ, Jia QW, Ji MY, et al: Circular RNA
profile in coronary artery disease. Am J Transl Res. 11:7115–7125.
2019.PubMed/NCBI
|
|
13
|
Li CY, Ma L and Yu B: Circular RNA
hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells
proliferation and angiogenesis. Biomed Pharmacother. 95:1514–1519.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feinberg MW and Moore KJ: MicroRNA
regulation of atherosclerosis. Circ Res. 118:703–720. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dlouhá D and Hubáček JA: Regulatory RNAs
and cardiovascular disease- with a special focus on circulating
microRNAs. Physiol Res. 66(Suppl 1): S21–S38. 2017. View Article : Google Scholar
|
|
16
|
Wojciechowska A, Braniewska A and
Kozar-Kamińska K: MicroRNA in cardiovascular biology and disease.
Adv Clin Exp Med. 26:865–874. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao G, Chen W, Liu M, Yan X and Yang P:
Circulating MicroRNAs as novel potential biomarkers for left
ventricular remodeling in postinfarction heart failure. Dis
Markers. 2019:50938032019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muendlein A, Geiger K, Leiherer A, Saely
CH, Fraunberger P and Drexel H: Evaluation of the associations
between circulating microRNAs and kidney function in coronary
angiography patients. Am J Physiol Renal Physiol. 318:F315–F321.
2020. View Article : Google Scholar
|
|
19
|
Shahbazi R, Baradaran B, Khordadmehr M,
Safaei S, Baghbanzadeh A, Jigari F and Ezzati H: Targeting ROCK
signaling in health, malignant and non-malignant diseases. Immunol
Lett. 219:15–26. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okamoto R, Li Y, Noma K, Hiroi Y, Liu PY,
Taniguchi M, Ito M and Liao JK: FHL2 prevents cardiac hypertrophy
in mice with cardiac-specific deletion of ROCK2. FASEB J.
27:1439–1449. 2013. View Article : Google Scholar :
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Singh RB, Mengi SA, Xu YJ, Arneja AS and
Dhalla NS: Pathogenesis of atherosclerosis: A multifactorial
process. Exp Clin Cardiol. 7:40–53. 2002.PubMed/NCBI
|
|
23
|
Yang L, Yang F, Zhao H, Wang M and Zhang
Y: Circular RNA circCHFR facilitates the proliferation and
migration of vascular smooth muscle via miR-370/FOXO1/Cyclin D1
pathway. Mol Ther Nucleic Acids. 16:434–441. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song CL, Wang JP, Xue X, Liu N, Zhang XH,
Zhao Z, Liu JG, Zhang CP, Piao ZH, Liu Y and Yang YB: Effect of
circular ANRIL on the inflammatory response of vascular endothelial
cells in a rat model of coronary atherosclerosis. Cell Physiol
Biochem. 42:1202–1212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Song G, Yuan J, Qiao S, Xu S, Si
Z, Yang Y, Xu X and Wang A: Circular RNA circ_0003204 inhibits
proliferation, migration and tube formation of endothelial cell in
atherosclerosis via miR-370-3p/TGFbetaR2/phosph-SMAD3 axis. J
Biomed Sci. 27:112020. View Article : Google Scholar
|
|
26
|
Liu H, Ma X, Mao Z, Shen M, Zhu J and Chen
F: Circular RNA has_circ_0003204 inhibits oxLDL-induced vascular
endothelial cell proliferation and angiogenesis. Cell Signal.
70:1095952020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen M, Li W, Zhang Y and Yang J:
MicroRNA-20a protects human aortic endothelial cells from
Ox-LDL-induced inflammation through targeting TLR4 and TXNIP
signaling. Biomed Pharmacother. 103:191–197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang D, Wang Y, Ma J, Wang W, Sun B, Zheng
T, Wei M and Sun Y: MicroRNA-20a participates in the aerobic
exercise-based prevention of coronary artery disease by targeting
PTEN. Biomed Pharmacother. 95:756–763. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou Q, Mei Y, Shoji T, Han X, Kaminski K,
Oh GT, Ongusaha PP, Zhang K, Schmitt H, Moser M, et al:
Rho-associated coiled-coil-containing kinase 2 deficiency in bone
marrow-derived cells leads to increased cholesterol efflux and
decreased atherosclerosis. Circulation. 126:2236–2247. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mattaliano MD, Wooters J, Shih HH and
Paulsen JE: ROCK2 associates with lectin-like oxidized LDL
receptor-1 and mediates oxidized LDL-induced IL-8 production. Am J
Physiol Cell Physiol. 298:C1180–1187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang L, Dai F, Tang L, Bao X, Liu Z,
Huang C, Zhang T and Yao W: Distinct roles for ROCK1 and ROCK2 in
the regulation of oxldl-mediated endothelial dysfunction. Cell
Physiol Biochem. 49:565–577. 2018. View Article : Google Scholar : PubMed/NCBI
|
